Silver Book Fact

The use of ACE inhibitors in hypertensive patients 80 years of older was associated in this study with a 30% reduction in the rate of stroke and a 64% reduction in the rate of heart failure. Additionally, these patients had 39% fewer fatal strokes, a 23% lower rate of cardiovascular events, and 21% fewer deaths from all causes.

Beckett N, Peters R, Fletcher A, Staessen J, et al. Treatment of Hypertension in Patients 80 Years of Age or Older. NEJM. 2008; 358(18): 1887-98. http://content.nejm.org/cgi/content/short/NEJMoa0801369

Reference

Title
Treatment of Hypertension in Patients 80 Years of Age or Older
Publication
NEJM
Publication Date
2008
Authors
Beckett N, Peters R, Fletcher A, Staessen J, et al
Volume & Issue
Volume 358, Issue 18
Pages
1887-98
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Greater use of clot-busting drug t-PA in ischemic stroke patients could save the health care system over $100 million a year.  
  • From approval in 2011 through 2015 >54,000 TAVRs were performed in 418 centers in 48 states
     
  • According to the National Institutes of Health, use of the clot-busting drug t-PA saves $4,400 per patient in hospitalization and nursing home costs.  
  • Using medical imaging to diagnose and treat stroke leads to better outcomes and shorter hospital stays, which yields a net economic benefit of about $8 billion over 10 years.  
  • Savings associated with t-PA treatment for ischemic stroke patients
    A $600 net savings is associated with each ischemic stroke patient treated with t-PA. In 2005, only 2% of all ischemic stroke patients received t-PA. If that percentage was increased…